Carcinogenesis Advance Access published online on March 28, 2003
Carcinogenesis, doi:10.1093/carcin/bgg044
© 2003 by Oxford University Press
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
CANCER BIOLOGY
1 Ludwig Institute for Cancer Research, Imperial College of Science, Technology and Medicine at St. Mary's Campus. Norfolk Place, London, W2 1PG. U.K.
* Corresponding author. E-mail: x.lu{at}ic.ac.uk.
Received 17 June 2002
; revised 23 December 2003
; accepted 3 March 2003
The p53 tumour suppressor gene is a transcription factor that can induce cell cycle arrest and apoptosis. In response to various stress-inducing signals, p53 level increases and this accompanied with increased activities of p53. Interestingly, the methylxanthine caffeine can abrogate the p53 accumulation induced by certain DNA-damaging agents by an unknown mechanism. In an effort to understand how different signals induce p53, human tumour cell lines were treated with combinations of various stress-inducing agents and caffeine. Caffeine inhibited the accumulation of p53 induced by Leptomycin B (LMB), an inhibitor of CRM1, but not ALLN, a proteasome inhibitor. Furthermore, caffeine also inhibited the accumulation of p53 by a variety of stress-inducing agents in vivo, such as 5-fluorouracil, doxorubicin, mitomycin C, camptothecin, and roscovitine. However, caffeine failed to affect the accumulation of p53 in hypoxia-treated cells. These results suggested that hypoxia must use a distinct pathway from most DNA damaging and stress inducing agents to induce p53.
Hypoxia induces p53 through a pathway distinct from most DNA damaging and stress-inducing agents
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
R. Helton, J. Cui, J. R. Scheel, J. A. Ellison, C. Ames, C. Gibson, B. Blouw, L. Ouyang, I. Dragatsis, S. Zeitlin, et al. Brain-Specific Knock-Out of Hypoxia-Inducible Factor-1{alpha} Reduces Rather Than Increases Hypoxic-Ischemic Damage J. Neurosci., April 20, 2005; 25(16): 4099 - 4107. [Abstract] [Full Text] [PDF] |
||||
![]() |
G.-i. Kusakai, A. Suzuki, T. Ogura, S.'i. Miyamoto, A. Ochiai, M. Kaminishi, and H. Esumi ARK5 Expression in Colorectal Cancer and Its Implications for Tumor Progression Am. J. Pathol., March 1, 2004; 164(3): 987 - 995. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A. Seta and D. E. Millhorn Functional genomics approach to hypoxia signaling J Appl Physiol, February 1, 2004; 96(2): 765 - 773. [Abstract] [Full Text] [PDF] |
||||


